(19)
(11) EP 4 142 702 A1

(12)

(43) Date of publication:
08.03.2023 Bulletin 2023/10

(21) Application number: 21731597.7

(22) Date of filing: 02.05.2021
(51) International Patent Classification (IPC): 
A61K 31/13(2006.01)
A61K 31/357(2006.01)
A61K 31/40(2006.01)
A61K 31/4427(2006.01)
A61K 31/506(2006.01)
A61K 31/64(2006.01)
A61K 31/7072(2006.01)
A61K 31/708(2006.01)
A61K 31/155(2006.01)
A61K 31/375(2006.01)
A61K 31/433(2006.01)
A61K 31/495(2006.01)
A61K 31/517(2006.01)
A61K 31/704(2006.01)
A61K 31/7076(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 45/06; A61K 31/708; A61K 31/13; A61K 31/64; A61K 31/506; A61K 31/40; A61K 31/4427; A61K 31/375; A61K 31/704; A61K 31/495; A61K 31/7076; A61K 31/7072; A61K 31/517; A61K 31/357; A61K 31/433; A61K 31/155; A61P 31/14
(86) International application number:
PCT/IL2021/050501
(87) International publication number:
WO 2021/220284 (04.11.2021 Gazette 2021/44)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 01.05.2020 US 202063018598 P
24.11.2020 US 202063117619 P

(71) Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
91390 Jerusalem (IL)

(72) Inventors:
  • ARKIN, Isaiah
    9083600 Har Adar (IL)
  • SINGH TOMAR, Prabhat Pratap
    9767101 Jerusalem (IL)
  • KRUGLIAK, Miriam
    9063100 Beit El (IL)

(74) Representative: Boult Wade Tennant LLP 
Salisbury Square House 8 Salisbury Square
London EC4Y 8AP
London EC4Y 8AP (GB)

   


(54) E PROTEIN CHANNEL BLOCKERS AND ORF3 INHIBITORS AS ANTI-COVID-19 AGENTS